AMPLEXA GENETICS A/S: Financial statements 2012
CVR: 29428441
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
AMPLEXA GENETICS A/S (CVR 29428441) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -538,092 and a net result of DKK -2,070,084. Equity in the 2012 report amounted to DKK -6,961,218.
- Gross Profit
- DKK -538,092
- Profit/Loss
- DKK -2,070,084
- Equity
- DKK -6,961,218
- Total Assets
- DKK 5,411,912
Keep an eye on AMPLEXA GENETICS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout AMPLEXA GENETICS A/S
AMPLEXA GENETICS A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Hans Atli Eli Albinus Dahl. The company is owned by SCIENT. INVEST ApS, Conseco P/F and Sp/f D65 Holding. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 4,009,035 and a net result of DKK -1,583,233 compared with DKK -11,108,344 the year before. Equity in the 2025 report amounted to DKK -10,313,267.